ArticleAME case reports2026

Severe renal toxicity following adjuvant envafolimab in a patient with ultra-hypermutated (POLE) stage II colorectal cancer: a case report.

Zi Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.